Moria, Inc.
April 30, 2007
San Diego
At the Moria speakers’ forum during the symposium of the American Society of Cataract and Refractive Surgeons, Dr. Michael Endl of Fichte-Endl Eye Associates presented the results of a retrospective analysis of patients treated with flapless Epi-LASIK compared to patients treated with femtosecond LASIK. After six weeks, the Epi-LASIK patients had better visual outcomes, more accurate results, and greater improvement in ablation profiles than the patients treated with the femtosecond device. The study covered a total of 218 patients - one group treated with the Moria Epi-K™, and another group treated with the IntraLase® 60 kHz laser.
Dr. Endl is not a paid consultant of Moria. In his practice, Epi-LASIK now accounts for over 48% of all laser vision correction patients.
The Moria Epi-K™ is the world’s leading epikeratome. The latest ASCRS survey of trends in refractive surgery, which was also presented during the ASCRS meeting, indicated a strong trend toward surface ablation, and that in 2006, the Moria Epi-K™ was the most commonly used epikeratome by 69% of respondents, an increase from 54% in 2005.
For further information, please contact Moria.
Don Mikes
Vice President, Global Marketing
Moria, Inc.
1050 Cross Keys Drive
Doylestown, PA 18902
Tel: 1 800 441 1314
[email protected]
Paul Rollier
Vice President, International
Moria S.A.
92160 Antony, France
Tel: 33 (0) 1 46 74 46 74
[email protected]